tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksMost Visited WebsitesDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by Upside
New
Top ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
New
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock ScreenerETF Screener
Popular
Trending StocksDaily Analyst RatingsCompare StocksCompare ETFsPenny Stock ScreenerTechnical Analysis ScreenerDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Personal Finance CenterMortgagesLoansInvesting & RetirementSpending & Savings
Calculators
401k Retirement CalculatorMortgage Calculator
Popular
Compound Interest CalculatorDollar Cost Averaging
New
Student Loan CalculatorAuto Loan Calculator
Education
How To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsTop Online BrokersBecome an Affiliate
Follow Us
NewsTrendingPortfolio
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Top ETFs
Top Smart Score Stocks
Popular
Earnings
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
Most Visited Websites
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Stock Screener
ETF Screener
Popular
Trending Stocks
Daily Analyst Ratings
Compare Stocks
Compare ETFs
Penny Stock Screener
Technical Analysis Screener
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
Follow Us

PULM Stock Latest News

MannKind to in-license iSPERSE technology from Pulmatrix
The FlyMannKind to in-license iSPERSE technology from Pulmatrix
2M ago
MNKD
PULM
Pulmatrix enters cross license agreement with MannKind
PremiumThe Fly
Pulmatrix enters cross license agreement with MannKind
2M ago
MNKD
PULM
Pulmatrix files $95M mixed securities shelf
PremiumThe Fly
Pulmatrix files $95M mixed securities shelf
2M ago
PULM
Pulmatrix announces results from PUR3100 study
PremiumThe Fly
Pulmatrix announces results from PUR3100 study
2M ago
PULM
Pulmatrix Publishes Study on Inhalable Migraine Treatment
PremiumCompany Announcements
Pulmatrix Publishes Study on Inhalable Migraine Treatment
2M ago
8K
PULM
Pulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
PremiumPress ReleasesPulmatrix Announces First Quarter 2024 Financial Results and Provides Corporate Update
2M ago
PULM
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
PremiumThe Fly
Pulmatrix reports Q1 EPS 23c vs ($1.22) last year
2M ago
PULM
Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Pulmatrix Announces Year-End and Q4 2023 Financial Results and Provides Corporate Update
4M ago
PULM
PULM Earnings this Week: How Will it Perform?
PremiumPre-Earnings
PULM Earnings this Week: How Will it Perform?
4M ago
PULM
Pulmatrix Shifts to Outsourced CMO Model, Terminates Executive
PremiumCompany Announcements
Pulmatrix Shifts to Outsourced CMO Model, Terminates Executive
4M ago
8K
PULM
Pulmatrix to Present at Investor Conferences, Limits Updates
PremiumCompany Announcements
Pulmatrix to Present at Investor Conferences, Limits Updates
4M ago
8K
PULM
Pulmatrix to stop patient enrollment of the Ph2b study of PUR1900
PremiumThe Fly
Pulmatrix to stop patient enrollment of the Ph2b study of PUR1900
6M ago
PULM
Pulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress ReleasesPulmatrix Announces Third Quarter 2023 Financial Results and Provides Corporate Update
8M ago
PULM
Pulmatrix’s IND application for PUR3100 to treat acute migraine accepted by FDA
PremiumThe Fly
Pulmatrix’s IND application for PUR3100 to treat acute migraine accepted by FDA
10M ago
PULM
Pulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Pulmatrix Announces Second Quarter 2023 Financial Results and Provides Corporate Update
11M ago
PULM
Pulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
PremiumThe Fly
Pulmatrix submits NDA to FDA to initiate Phase 2 trial of PUR3100
1y ago
PULM
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
PremiumThe Fly
Pulmatrix to present Phase 1 data of PUR3100 in acute migraine
1y ago
PULM
Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
PremiumPress Releases
Pulmatrix Announces First Quarter 2023 Financial Results and Provides Corporate Update
1y ago
PULM
Pulmatrix Announces Year-End and Q4 Financial 2022 Results and Provides Corporate Update
PremiumPress Releases
Pulmatrix Announces Year-End and Q4 Financial 2022 Results and Provides Corporate Update
1y ago
PULM
Pulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
PremiumThe FlyPulmatrix reports Q4 revenue $6.1M vs. $5.2M last year
1y ago
PULM
Pulmatrix (PULM) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
Pulmatrix (PULM) Q4 Earnings Cheat Sheet
1y ago
PULM
Pulmatrix dosed first patient in Phase 2b trial of PUR1900
PremiumThe Fly
Pulmatrix dosed first patient in Phase 2b trial of PUR1900
1y ago
PULM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >